» Articles » PMID: 36532766

Precision Caffeine Therapy for Apnea of Prematurity and Circadian Rhythms: New Possibilities Open Up

Overview
Journal Front Pharmacol
Date 2022 Dec 19
PMID 36532766
Authors
Affiliations
Soon will be listed here.
Abstract

Caffeine is the globally consumed psychoactive substance and the drug of choice for the treatment of apnea of prematurity (AOP), but its therapeutic effects are highly variable among preterm infants. Many of the molecular underpinnings of the marked individual response have remained elusive yet. Interestingly, the significant association between gene polymorphisms and the response to caffeine therapy offers an opportunity to advance our understanding of potential mechanistic pathways. In this review, we delineate the functions and mechanisms of human circadian rhythms. An up-to-date advance of the formation and ontogeny of human circadian rhythms during the perinatal period are concisely discussed. Specially, we summarize and discuss the characteristics of circadian rhythms in preterm infants. Second, we discuss the role of caffeine consumption on the circadian rhythms in animal models and human, especially in neonates and preterm infants. Finally, we postulate how circadian-based therapeutic initiatives could open new possibilities to promote precision caffeine therapy for the AOP management in preterm infants.

Citing Articles

Circadian rhythm development in preterm infants. The role of postnatal versus postmenstrual age.

Govindan R, Andescavage N, Basu S, Murnick J, Ngwa J, Galla J Early Hum Dev. 2024; 196:106084.

PMID: 39126762 PMC: 11344654. DOI: 10.1016/j.earlhumdev.2024.106084.


Association between PER and CRY gene polymorphisms and the response to caffeine citrate treatment in infants with apnea of prematurity.

Xie J, Zhuang W, Zhu Y, Zheng Z, Huang Y, Ma S Front Pediatr. 2024; 12:1414185.

PMID: 39108697 PMC: 11301747. DOI: 10.3389/fped.2024.1414185.


Cardiorespiratory and Neuroprotective Effects of Caffeine in Neonate Animal Models.

Mota-Rojas D, Villanueva-Garcia D, Hernandez-Avalos I, Casas-Alvarado A, Dominguez-Oliva A, Lezama-Garcia K Animals (Basel). 2023; 13(11).

PMID: 37889643 PMC: 10252037. DOI: 10.3390/ani13111769.

References
1.
Bory C, Baltassat P, Porthault M, BETHENOD M, FREDERICH A, Aranda J . Metabolism of theophylline to caffeine in premature newborn infants. J Pediatr. 1979; 94(6):988-93. DOI: 10.1016/s0022-3476(79)80246-2. View

2.
Hayes M, Akilesh M, Fukumizu M, Gilles A, Sallinen B, Troese M . Apneic preterms and methylxanthines: arousal deficits, sleep fragmentation and suppressed spontaneous movements. J Perinatol. 2007; 27(12):782-9. DOI: 10.1038/sj.jp.7211820. View

3.
Fairchild K, Mohr M, Paget-Brown A, Tabacaru C, Lake D, Delos J . Clinical associations of immature breathing in preterm infants: part 1-central apnea. Pediatr Res. 2016; 80(1):21-7. PMC: 5015591. DOI: 10.1038/pr.2016.43. View

4.
Carnielli V, Verlato G, Benini F, Rossi K, Cavedagni M, Filippone M . Metabolic and respiratory effects of theophylline in the preterm infant. Arch Dis Child Fetal Neonatal Ed. 2000; 83(1):F39-43. PMC: 1721103. DOI: 10.1136/fn.83.1.f39. View

5.
Weisman O, Magori-Cohen R, Louzoun Y, Eidelman A, Feldman R . Sleep-wake transitions in premature neonates predict early development. Pediatrics. 2011; 128(4):706-14. DOI: 10.1542/peds.2011-0047. View